Keywords
Therapeutics ×
Anesthesiology ×
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

7 Search results.

Eradicate source of infection CandiSep Anesthesiology and Intensive Care NCT02734550 - Eradicate source of infection

- 7/3/18 - 1 form, 1 itemgroup, 8 items, 1 language
Itemgroup: Eradicate source of infection
Study part: Eradicate source of infection Time interval 24 hours before randomization, Time interval after randomization and Day 1 to 14. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Volume Therapy CandiSep Anesthesiology and Intensive Care NCT02734550 - Volume Therapy

- 7/3/18 - 1 form, 1 itemgroup, 5 items, 1 language
Itemgroup: Infusion Therapy
Study part: Volume Therapy Time interval 24 hours before randomization, Time interval after randomization and Day 1 to 14. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Vasopressors and Inotropics CandiSep Anesthesiology and Intensive Care NCT02734550 - Vasopressors and Inotropics

- 7/3/18 - 1 form, 1 itemgroup, 8 items, 1 language
Itemgroup: Vasopressors; inotropics
Study part: Vasopressors and Inotropics Time interval 24 hours before randomization, Time interval after randomization and Day 1 to 14. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Risk factors for invasive Candida infection Screening CandiSep Anesthesiology and Intensive Care NCT02734550 - Risk factors for invasive Candida infection Screening

- 7/3/18 - 1 form, 1 itemgroup, 9 items, 1 language
Itemgroup: Risk Factors; candida infection invasive
Study part: Risk factors for invasive Candida infection Screening. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Antifungal therapy CandiSep Anesthesiology and Intensive Care NCT02734550 - Antifungal therapy

- 6/3/18 - 1 form, 1 itemgroup, 18 items, 1 language
Itemgroup: Antifungal therapy
Study part: Antifungal therapy. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Antimicrobial therapy CandiSep Anesthesiology and Intensive Care NCT02734550 - Antimicrobial therapy

- 6/2/18 - 1 form, 1 itemgroup, 13 items, 1 language
Itemgroup: Antimicrobial therapy
Study part: Antimicrobial therapy . (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.

Adjuvant sepsis therapy CandiSep Anesthesiology and Intensive Care NCT02734550 - Adjuvant sepsis therapy

- 6/2/18 - 1 form, 1 itemgroup, 8 items, 1 language
Itemgroup: Adjuvant therapy Sepsis
Study part: Adjuvant sepsis therapy. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.